Skip to main content
Erschienen in: World Journal of Urology 1/2009

01.02.2009 | Original Article

Testicular metastases: a poor prognostic factor in patients with advanced prostate cancer

verfasst von: Fernando Korkes, Renato Gasperini, Karen Levy Korkes, Deusdedit Cortez Vieira Silva Neto, Marilia Germanos Castro

Erschienen in: World Journal of Urology | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Prostate cancer is the most frequently diagnosed neoplasm in men. In some patients, however, the disease pursues a clearly more aggressive course. Testicular metastases from prostate cancer are rare events that have been previously reported; however, its frequency and clinical meaning are not well established. The aim of the present study was, therefore, to evaluate its occurrence and clinical meaning.

Patients and methods

A review of patients who underwent androgen deprivation orchidectomy for prostate cancer between 1995 and 2007 was undertaken. On the period evaluated, 1,693 orchidectomies were performed at our institution. Since, the population of patients treated at our institution does not have access to the expensive androgen-deprivation drugs, the vast majority is treated through surgical castration. In such context, evaluation of testicular parenchyma of patients with advanced prostate cancer could be assessed. Clinical and histological data were reviewed, and patients with testicular metastases were identified.

Results

Of the 1,693 orchidectomies performed during the period analysed, three cases of testicular metastases of prostate cancer (range 58–76 years) were diagnosed (0.18%). All patients had very atypical neoplasm’s behaviour and poor prognosis, dying within the first year.

Conclusion

In conclusion, testicular metastases from prostate cancer are a rare event, observed in 1.8 per 1,000 cases. As other visceral metastases, testicular metastases might also be considered as an unusual additional factor of poor prognosis.
Literatur
1.
Zurück zum Zitat Boyle P, Maisonneuve P, Napalkov P (1995) Geographical and temporal patterns of incidence and mortality from prostate cancer. Urology 46(3 Suppl A):47–55PubMedCrossRef Boyle P, Maisonneuve P, Napalkov P (1995) Geographical and temporal patterns of incidence and mortality from prostate cancer. Urology 46(3 Suppl A):47–55PubMedCrossRef
2.
Zurück zum Zitat Adolfsson J, Steineck G, Hedlund PO (1999) Deferred treatment of locally advanced nonmetastatic prostate cancer: a long-term followup. J Urol 161(2):505–508PubMedCrossRef Adolfsson J, Steineck G, Hedlund PO (1999) Deferred treatment of locally advanced nonmetastatic prostate cancer: a long-term followup. J Urol 161(2):505–508PubMedCrossRef
3.
Zurück zum Zitat Jesus CM, Goldberg J, Camargo JL (2005) Single testicular metastasis mimicking primary testicular neoplasm: a rare manifestation of prostate cancer. Int Braz J Urol 31(1):54–56PubMedCrossRef Jesus CM, Goldberg J, Camargo JL (2005) Single testicular metastasis mimicking primary testicular neoplasm: a rare manifestation of prostate cancer. Int Braz J Urol 31(1):54–56PubMedCrossRef
4.
Zurück zum Zitat Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA et al (2002) Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features. Cancer 94(10):2610–2617PubMedCrossRef Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA et al (2002) Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features. Cancer 94(10):2610–2617PubMedCrossRef
5.
Zurück zum Zitat Benchekroun A, Kasmaoui EH, Ghadouane M, Jira H, Lachkar A, Marzouk M et al (2001) Testicular metastasis of prostatic adenocarcinoma. Report of a case. Ann Urol (Paris) 35(4):234–236 Benchekroun A, Kasmaoui EH, Ghadouane M, Jira H, Lachkar A, Marzouk M et al (2001) Testicular metastasis of prostatic adenocarcinoma. Report of a case. Ann Urol (Paris) 35(4):234–236
6.
Zurück zum Zitat Dutt N, Bates AW, Baithun SI (2000) Secondary neoplasms of the male genital tract with different patterns of involvement in adults and children. Histopathology 37(4):323–331PubMedCrossRef Dutt N, Bates AW, Baithun SI (2000) Secondary neoplasms of the male genital tract with different patterns of involvement in adults and children. Histopathology 37(4):323–331PubMedCrossRef
7.
Zurück zum Zitat Figg WD, Franks ME, Venzon D, Duray P, Cox MC, Linehan WM et al (2004) Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer. World J Urol 22(6):425–430PubMedCrossRef Figg WD, Franks ME, Venzon D, Duray P, Cox MC, Linehan WM et al (2004) Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer. World J Urol 22(6):425–430PubMedCrossRef
8.
Zurück zum Zitat Yossepowitch O, Bianco FJ Jr, Eggener SE, Eastham JA, Scher HI, Scardino PT (2007) The natural history of noncastrate metastatic prostate cancer after radical prostatectomy. Eur Urol 51(4):940–947 discussion 947–8PubMedCrossRef Yossepowitch O, Bianco FJ Jr, Eggener SE, Eastham JA, Scher HI, Scardino PT (2007) The natural history of noncastrate metastatic prostate cancer after radical prostatectomy. Eur Urol 51(4):940–947 discussion 947–8PubMedCrossRef
Metadaten
Titel
Testicular metastases: a poor prognostic factor in patients with advanced prostate cancer
verfasst von
Fernando Korkes
Renato Gasperini
Karen Levy Korkes
Deusdedit Cortez Vieira Silva Neto
Marilia Germanos Castro
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 1/2009
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-008-0322-8

Weitere Artikel der Ausgabe 1/2009

World Journal of Urology 1/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.